Purchase Order 75N91024P00203
Award Date
3/1/24
Potential Completion Date
8/31/24
Potential Value
$17K
Federal Agency
National Cancer Institute
Awardee
Becton, Dickinson And Company
Ultimate Awardee
Becton, Dickinson & Co
NAICS Category
811310 - Commercial and Industrial Machinery and Equipment (except Automotive and Electronic) Repair and Maintenance
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20852, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $20,809.08 firm fixed price purchase order to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for a service agreement. As the prime contractor, Becton, Dickinson and Company BD Biosciences will provide unspecified services to the National Cancer Institute, which conducts and supports research across the nation with the goal of discovering prevention and...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division a $13,713.30 firm fixed price purchase order for bridge maintenance agreement services. BD Biosciences will perform the services in Bethesda, Maryland over a period of four months concluding in December 2023. As the prime contractor, BD Biosciences specializes in providing research reagents and instruments that...
This is a federal contract award to Becton, Dickinson and Company (BD) by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), for maintenance services on government-owned Becton Dickinson instrumentation. The $141,480.00 firm fixed-price purchase order supports the work of the NCI's Center for Cancer Research, Experimental Immunology Branch. The contract has no set-aside designation and was awarded on February 1, 2017, with a completion date of January...
The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $25,181.16 delivery order against the Multiple Award Schedule contract vehicle to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division. BD Biosciences will provide maintenance services in support of the National Cancer Institute's research efforts located in Bethesda, Maryland under the firm fixed price contract running from August 1, 2023 through July 31, 2024....
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $14,154.60 firm fixed price delivery order to Becton, Dickinson and Company for maintenance services. The contract draws from Becton Dickinson's Multiple Award Schedule with the General Services Administration and has a period of performance through July 2024. Becton Dickinson will provide maintenance support for equipment previously delivered to the agency in San Jose, California to...
Becton, Dickinson and Company (BD) has been awarded a firm fixed price purchase order by the National Institutes of Health National Cancer Institute for $10,864.80. The contract calls for servicing an instrument used by approximately 75 personnel at the agency to conduct experiments involving costly reagents, animals, and extensive labor hours. Performance will take place in Bethesda, Maryland through April 2024. No set-aside designation was applied. This award is likely associated with...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed-price purchase order to Becton, Dickinson and Company (BD), a global medical technology company, for preventive maintenance, emergency service, support, and coverage for four government-owned BD Biosciences flow cytometry instruments. The one-year contract with four option years, valued at $148,833.48, provides for semi-annual preventive maintenance, on-site emergency repair...
This is a purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Becton, Dickinson And Company (BD) for a maintenance agreement. The contract has a firm fixed price of $17,387.91 and a completion date of July 26, 2024. BD is a global medical technology company that provides instruments, reagents, and services supporting biomedical research and clinical applications, particularly through flow cytometry, cell...
The U.S. National Cancer Institute has awarded a $154,840.80 firm fixed-price delivery order contract to Becton, Dickinson And Company (BD) for a maintenance agreement. This order is part of BD's existing Multiple Award Schedule (MAS) contract with the General Services Administration (GSA). The contract has a period of performance through January 31, 2028 and does not utilize a set-aside designation. BD is a major manufacturer and supplier of medical devices, instruments, reagents, and related...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price purchase order contract valued at under $1 million to Becton, Dickinson and Company IDS Division, a subsidiary of Becton, Dickinson and Company, to support investigating the role of MTOR in niche cells controlling B cell development in bone marrow under the direction of Dr. Mock's laboratory. Work will be performed in Sparks, Maryland through August 2023. No set aside...